Sentence examples for a balanced trial from inspiring English sources

In the interests of ensuring a balanced trial, all four treatment arms tracked covariate data on symptomology and recovery following concussion using standardized forms.

The cost and time required to develop these systems may not be feasible or viable given the small savings in sample size afforded by a balanced trial (Senn, 2004).

It is not clear why they did not choose 25 (the midpoint) to indicate a balanced trial and any score less than that would favour an explanatory study, while any score greater than 25 would favour a pragmatic study.

If a dimension could not be rated, it received a score of 0. Each trial could be allocated a total possible score of 50, with a range of 0 to 30 indicating an explanatory trial, 31 to 39 indicating a balanced trial and any score >35 indicating a pragmatic trial.

Results reported here show by means of a regression simulation that the estimate obtained from a dynamically balanced trial is unbiased, and a new estimate of its standard deviation is similarly shown to be unbiased.

– If the trial wasn't already just a political theatre, this clearly shows that this is not a fair and balanced trial.

On Friday, Francesco Maresca, the Kercher family lawyer, said of the fresh appeal: "The hopes are to have a complete, total, neutral and balanced trial which can then lead to a sentence which is properly developed and well-reasoned".

Patients who are likely to be offered antidepressants – i.e. those who have had at least one previous treated episode of major depression – could be pre-consented to take part in a balanced placebo trial in the future.

Trials were presented in 4 runs, with 12 trials per run, and a balanced number of trial types within runs.

The higher sensitivity of severely unbalanced trials to the a priori-postulated value of the ICC compared to that of balanced trials emphasized the necessity of a sensitivity analysis on this parameter.

14 From the perspective of a reimbursement agency, the key finding of this analysis is that the time-of-response measurement and baseline disease activity may act as treatment-effect modifiers, suggesting that when these variables are not distributed in a balanced way across trials, there is potential for confounding bias in the resulting meta-analysis estimates.